Total Funding
81
28
Total FundingVenture - Series Unknown raised
Growth Score 81 in past quarter
-5 pts
Heat Score 28 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
316037
CureDM is a biopharmaceutical company developing therapies that can prevent, ameliorate and reverse diabetes.
Acquired by 

Boston Therapeutics
Rita El-Hajj: Founder
About the Company
CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.
Women Founded


